Pax2 downregulation has been shown to lead to growth inhibition of cancer cells, and reactivation of Pax2 is also observed in clear cell renal cell carcinoma, a tumor type characterized by loss of VHL tumor suppressor function (169). The gene discussed is PAX2; the disease is neoplasm.